[{"address1": "225 Franklin Street", "address2": "26th Floor", "city": "Boston", "state": "MA", "zip": "02110", "country": "United States", "phone": "857 246 8998", "website": "https://www.pieris.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Pieris Pharmaceuticals, Inc., a biotechnology company, discovers and develops biotechnological applications. The company focuses on the development of its 4-1BB bispecifics immuno-oncology (IO) programs. Its clinical pipeline consists of IO bispecifics, including S095012 (PRS-344), a bispecific Mabcalin compound targeting PD-L1 and 4-1BB in partnership with Les Laboratoires Servier and Institut de Recherches Internationales Servier; SGN-BB228 (PRS-346), a CD228 x 4-1BB bispecific antibody-Anticalin compound targeting CD228 and 4-1BB in partnership with Pfizer Inc.; and BOS-342 (PRS-342), a GPC3 x 4-1BB bispecific Mabcalin compound targeting GPC3 and 4-1BB in partnership with Boston Pharmaceuticals, which are in phase 1 studies. The company was founded in 2001 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 46, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stephen S. Yoder J.D.", "age": 47, "title": "CEO, President & Director", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 744134, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas  Bures", "age": 48, "title": "Senior VP, CFO & Treasurer", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 487501, "exercisedValue": 0, "unexercisedValue": 5120349}, {"maxAge": 1, "name": "Dr. Shane  Olwill Ph.D.", "age": 47, "title": "Senior VP & Chief Development Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 463909, "exercisedValue": 0, "unexercisedValue": 8086283}, {"maxAge": 1, "name": "Maria  Kelman", "title": "Executive Director of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Prompong  Chaikul", "age": 36, "title": "Chief Supply Chain Officer", "yearBorn": 1987, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Florian  Witte Ph.D.", "title": "VP and Head of Alliance Management & Early Project Leadership", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 15.52, "open": 15.58, "dayLow": 14.3, "dayHigh": 16.0, "regularMarketPreviousClose": 15.52, "regularMarketOpen": 15.58, "regularMarketDayLow": 14.3, "regularMarketDayHigh": 16.0, "beta": 0.68, "forwardPE": -75.799995, "volume": 224152, "regularMarketVolume": 224152, "averageVolume": 129430, "averageVolume10days": 79370, "averageDailyVolume10Day": 79370, "bid": 14.8, "ask": 15.74, "bidSize": 100, "askSize": 100, "marketCap": 20014838, "fiftyTwoWeekLow": 6.2, "fiftyTwoWeekHigh": 41.76, "priceToSalesTrailing12Months": 0.4890375, "fiftyDayAverage": 10.81802, "twoHundredDayAverage": 13.424235, "currency": "USD", "enterpriseValue": 930838, "profitMargins": -0.3971, "floatShares": 613265, "sharesOutstanding": 1320240, "sharesShort": 10278, "sharesShortPriorMonth": 13488, "sharesShortPreviousMonthDate": 1718323200, "dateShortInterest": 1721001600, "sharesPercentSharesOut": 0.0078, "heldPercentInsiders": 0.06969, "heldPercentInstitutions": 0.54428, "shortRatio": 0.29, "shortPercentOfFloat": 0.0097, "bookValue": 17.76, "priceToBook": 0.8536036, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -16252000, "trailingEps": -11.4, "forwardEps": -0.2, "lastSplitFactor": "2:1", "lastSplitDate": 1417996800, "enterpriseToRevenue": 0.023, "enterpriseToEbitda": -0.241, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PIRS", "underlyingSymbol": "PIRS", "shortName": "Pieris Pharmaceuticals, Inc.", "longName": "Pieris Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1420209000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "8fe43177-b19a-3ae9-9f2a-563a55a71915", "gmtOffSetMilliseconds": -14400000, "currentPrice": 15.16, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 19084000, "totalCashPerShare": 14.455, "ebitda": -3861000, "quickRatio": 3.495, "currentRatio": 3.916, "totalRevenue": 40927000, "revenuePerShare": 34.041, "returnOnAssets": -0.063039996, "returnOnEquity": -0.86858004, "freeCashflow": -32178500, "operatingCashflow": -49819000, "revenueGrowth": -0.973, "grossMargins": 0.27688, "ebitdaMargins": -0.09434, "operatingMargins": -100.0566, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-08-10"}]